JP2009528843A - 組換えヒトトロンビンおよびフィブリノゲンの調製法 - Google Patents

組換えヒトトロンビンおよびフィブリノゲンの調製法 Download PDF

Info

Publication number
JP2009528843A
JP2009528843A JP2008558377A JP2008558377A JP2009528843A JP 2009528843 A JP2009528843 A JP 2009528843A JP 2008558377 A JP2008558377 A JP 2008558377A JP 2008558377 A JP2008558377 A JP 2008558377A JP 2009528843 A JP2009528843 A JP 2009528843A
Authority
JP
Japan
Prior art keywords
human
recombinant
thrombin
fibrinogen
prothrombin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008558377A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009528843A5 (enExample
Inventor
カート・オスサー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Humagene Inc
Original Assignee
Humagene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Humagene Inc filed Critical Humagene Inc
Publication of JP2009528843A publication Critical patent/JP2009528843A/ja
Publication of JP2009528843A5 publication Critical patent/JP2009528843A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
JP2008558377A 2006-03-06 2007-03-06 組換えヒトトロンビンおよびフィブリノゲンの調製法 Pending JP2009528843A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77947406P 2006-03-06 2006-03-06
US84394506P 2006-09-12 2006-09-12
PCT/US2007/005845 WO2007103447A2 (en) 2006-03-06 2007-03-06 A method for the preparation of recombinant human thrombin

Publications (2)

Publication Number Publication Date
JP2009528843A true JP2009528843A (ja) 2009-08-13
JP2009528843A5 JP2009528843A5 (enExample) 2010-04-22

Family

ID=38475538

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008558377A Pending JP2009528843A (ja) 2006-03-06 2007-03-06 組換えヒトトロンビンおよびフィブリノゲンの調製法

Country Status (8)

Country Link
US (2) US20100159512A1 (enExample)
EP (2) EP1996186A4 (enExample)
JP (1) JP2009528843A (enExample)
CN (1) CN101501216B (enExample)
AU (1) AU2007223880A1 (enExample)
CA (1) CA2644926A1 (enExample)
RU (1) RU2008139428A (enExample)
WO (1) WO2007103447A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9447167B2 (en) 2011-03-03 2016-09-20 Immuno-Biological Laboratories Co., Ltd Fibrinogen-producing transgenic silkworm

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009223115B2 (en) 2008-03-14 2015-09-24 Humanzyme, Inc. Recombinant production of authentic human proteins using human cell expression systems
EP3225252A1 (en) 2008-05-02 2017-10-04 Laboratoire Français du Fractionnement et des Biotechnologies Treatment of bleeding with low half-life fibrinogen
NZ590871A (en) * 2008-07-09 2012-07-27 Profibrix Bv Recombinant fibrinogen
FR2942232B1 (fr) * 2009-02-19 2015-03-13 Lfb Biotechnologies Moyens pour la purification d'une proteine de la coagulation et procedes pour sa mise en oeuvre
US20120164111A1 (en) 2009-04-14 2012-06-28 Kurt Osther Novel post-translational fibrinogen variants
PL2624859T3 (pl) * 2010-10-06 2017-09-29 Medimmune Limited Czynnik ii samodzielnie lub w skojarzeniu z dalszymi czynnikami do leczenia zaburzeń hemostazy powiązanych z koagulopatią z rozcieńczenia
CN102690803B (zh) * 2011-03-24 2015-04-29 苏州泽璟生物制药有限公司 一种重组人凝血酶在动物细胞内的高效表达和生产方法
EP2556842A1 (en) 2011-08-11 2013-02-13 Bioftalmik, S.L. Composition in the form of film comprising fibrinogen and a fibrinogen activator and the applications thereof
HK1199908A1 (en) 2011-09-06 2015-07-24 Medimmune, Llc Methods for processing coagulation factors
WO2014115087A2 (en) * 2013-01-22 2014-07-31 Cencor Biotech Ltd. A method for the preparation of recombinant human prothrombin and fibrinogen
EP3274367A1 (en) * 2015-03-23 2018-01-31 Dana Genetic A/S Recombinant soluble human tissue factor, method of its production and uses thereof
WO2016176440A2 (en) * 2015-04-28 2016-11-03 Saint Louis University Thrombin-thrombomodulin fusion proteins as protein c activators
WO2017189943A1 (en) * 2016-04-28 2017-11-02 Saint Louis University Thrombin-thrombomodulin fusion proteins as a powerful anticoagulant
BR102017004788B1 (pt) * 2017-03-09 2021-03-23 Instituto De Biologia Molecular Do Paraná - Ibmp. Método de produção de cola de fibrina de origem recombinante
EP3618853B1 (en) * 2018-04-24 2020-09-09 Fibriant B.V. Fibrinogen gamma prime variants for use in treating an infection
JP2025519280A (ja) 2022-05-17 2025-06-25 ユリウス－マキシミリアンズ－ユニヴァーシタエト ビュルツブルク 手術創ケア用のフィブリンシーラントのための新規組換えフィブリノーゲンバリアント
CN116333094B (zh) * 2023-02-04 2024-03-29 山东多美康生物医药有限公司 一种重组人源化I型胶原蛋白α1及表达载体和应用
CN116218864B (zh) * 2023-04-10 2024-01-09 山东多美康生物医药有限公司 一种重组Ⅲ型人源化胶原蛋白α1及其表达载体和应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06153931A (ja) * 1992-08-24 1994-06-03 Interpharm Lab Ltd 無血清培地
WO2003004641A1 (en) * 2001-07-06 2003-01-16 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Process for producing human thrombin by gene modification technique
JP2003510070A (ja) * 1999-09-28 2003-03-18 バクスター アクチェンゲゼルシャフト 細胞の無タンパク質かつ無血清の培養のための培地
WO2004007714A1 (ja) * 2002-07-17 2004-01-22 Asahi Kasei Pharma Corporation ヒトプロトロンビン類似体およびヒトメゾトロンビン類似体
JP2004283097A (ja) * 2003-03-24 2004-10-14 National Veterinary Assay Laboratory Ministry Of Agriculture Forestry & Fisheries 動物由来成分無添加培養液およびそれを用いる細胞系の作出方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US722366A (en) 1901-09-09 1903-03-10 Lars Peter Larsen Regenerative apparatus for the simultaneous warming and cooling of milk.
ATE20824T1 (de) 1981-06-25 1986-08-15 Serapharm Gmbh & Co Kg Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundheilung.
US4442655A (en) 1981-06-25 1984-04-17 Serapharm Michael Stroetmann Fibrinogen-containing dry preparation, manufacture and use thereof
US4546082A (en) 1982-06-17 1985-10-08 Regents Of The Univ. Of California E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
US4870008A (en) 1983-08-12 1989-09-26 Chiron Corporation Secretory expression in eukaryotes
US4613572A (en) 1983-08-15 1986-09-23 Kansas State University Research Foundation Yeast BAR1 gene plasmid
US4931373A (en) 1984-05-25 1990-06-05 Zymogenetics, Inc. Stable DNA constructs for expression of α-1 antitrypsin
EP0188555A4 (en) 1984-07-09 1988-04-18 Integrated Genetics Inc YEAST CLONING VEHICLE.
JPS6144825A (ja) 1984-08-09 1986-03-04 Unitika Ltd 止血剤
EP0243465A1 (en) 1985-10-25 1987-11-04 Vivian L. Mackay Method of using bar1 for secreting foreign proteins
US4965203A (en) 1987-01-28 1990-10-23 Warner-Lambert Company Purified thrombin preparations
CZ333492A3 (en) * 1991-11-12 1993-09-15 Lilly Co Eli Dipeptide of l-azetidine-2-carboxylic acids and l-argininaldehyde, process of its preparation and pharmaceutical preparation in which said dipeptide is comprised
US5572692A (en) 1991-12-24 1996-11-05 Intel Corporation Memory configuration decoding system having automatic row base address generation mechanism for variable memory devices with row access interleaving
US5527692A (en) 1991-12-31 1996-06-18 Zymogenetics, Inc. Methods for producing thrombin
JP3404038B2 (ja) 1991-12-31 2003-05-06 ザイモジェネティクス，インコーポレイティド トロンビンの製造方法
US5968817A (en) * 1993-03-15 1999-10-19 The Scripps Research Institute DNA encoding serotonin receptors
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
EP0728210B1 (en) * 1993-11-12 2005-04-13 Gilead Sciences, Inc. Thrombin mutants
US5639940A (en) 1994-03-03 1997-06-17 Pharmaceutical Proteins Ltd. Production of fibrinogen in transgenic animals
DE19605126A1 (de) * 1996-02-12 1997-08-14 Basf Ag Thrombinmuteine als Antidot für Thrombininhibitoren
US6037457A (en) 1997-01-31 2000-03-14 The University Of North Carolina At Chapel Hill Method for recombinant fibrinogen production
US6780411B2 (en) 1998-05-01 2004-08-24 Zymogenetics, Inc. Tissue sealant compositions
CA2446185C (en) * 2001-05-07 2013-06-18 National Research Council Of Canada Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells
CA2452767C (en) * 2001-07-06 2013-03-19 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Genetic recombinant ecarin and process for preparing the same
WO2003052059A2 (en) * 2001-12-14 2003-06-26 Eli Lilly And Company Recombinant bovine thrombin
GB0324044D0 (en) * 2003-10-14 2003-11-19 Astrazeneca Ab Protein
EP1676911B1 (en) * 2003-10-24 2010-04-21 Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute Novel recombinant animal cells with high protein production, method of constructing the same and method of mass protein production using the same
MX2007001294A (es) * 2004-08-17 2008-03-04 Zlb Behring Gmbh Polipeptidos modificados que dependen de vitamina k.
WO2008008862A2 (en) * 2006-07-11 2008-01-17 Invitrogen Corporation Proteome standards for mass spectrometry

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06153931A (ja) * 1992-08-24 1994-06-03 Interpharm Lab Ltd 無血清培地
JP2003510070A (ja) * 1999-09-28 2003-03-18 バクスター アクチェンゲゼルシャフト 細胞の無タンパク質かつ無血清の培養のための培地
WO2003004641A1 (en) * 2001-07-06 2003-01-16 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Process for producing human thrombin by gene modification technique
WO2004007714A1 (ja) * 2002-07-17 2004-01-22 Asahi Kasei Pharma Corporation ヒトプロトロンビン類似体およびヒトメゾトロンビン類似体
JP2004283097A (ja) * 2003-03-24 2004-10-14 National Veterinary Assay Laboratory Ministry Of Agriculture Forestry & Fisheries 動物由来成分無添加培養液およびそれを用いる細胞系の作出方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6012027949; Ｐｒｏｔｅｉｎ　Ｅｘｐｒ．　Ｐｕｒｉｆ． Ｖｏｌ．　８, 1996, ｐ．　３５８-３６４ *
JPN6012027950; Ｐｒｏｔｅｉｎ，　ＮＣＢＩ，　Ａｃｃｅｓｓｉｏｎ　Ｎｏ．　ＡＡＨ５１３３２　［ｏｎｌｉｎｅ］ , 20040630 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9447167B2 (en) 2011-03-03 2016-09-20 Immuno-Biological Laboratories Co., Ltd Fibrinogen-producing transgenic silkworm

Also Published As

Publication number Publication date
US20100159512A1 (en) 2010-06-24
EP1996186A4 (en) 2009-07-22
EP2407561A2 (en) 2012-01-18
WO2007103447A2 (en) 2007-09-13
CN101501216A (zh) 2009-08-05
CA2644926A1 (en) 2007-09-13
US20130017591A1 (en) 2013-01-17
RU2008139428A (ru) 2010-05-20
WO2007103447A3 (en) 2008-12-11
EP2407561A3 (en) 2012-05-30
WO2007103447A8 (en) 2008-05-15
AU2007223880A1 (en) 2007-09-13
CN101501216B (zh) 2013-10-02
EP1996186A2 (en) 2008-12-03

Similar Documents

Publication Publication Date Title
JP2009528843A (ja) 組換えヒトトロンビンおよびフィブリノゲンの調製法
JP2021078526A (ja) 第ｉｘ因子融合タンパク質及びそれらの製造方法及び使用方法
EA020818B1 (ru) Модифицированные полипептиды фактора vii и их применение
KR20080109750A (ko) 연장된 반감기를 갖는 변형된 응고 인자 ＶＩＩａ
ES2574584T3 (es) Transfección estable sin suero y producción de proteinas humanas recombinantes en líneas celulares humanas
EA012566B1 (ru) Химерный белок, способ его получения и способ лечения заболеваний с применением химерного белка
JPH02442A (ja) エリトロポエチンを発現するヒトｃＤＮＡのクローニング方法
US20090169553A1 (en) Novel Protein Fusion/Tag Technology
KR100711312B1 (ko) 섬유소용해 활성을 갖는 폴리펩티드 및 이의 제조방법
US20160024487A1 (en) Thrombin sensitive coagulation factor x molecules
JP2009533364A (ja) 治療用ポリペプチドのインビボでの回収を増大させる方法
JP2007509843A (ja) 第ＶＩＩ／ＶＩＩａ因子活性を有するハイブリッド分子
JP7319187B2 (ja) 長時間作用型凝固因子ｖｉｉおよびその製造方法
US6517830B1 (en) Compositions and methods for the expression of factor VIII polypeptides and uses therefor
JPH04505554A (ja) 可溶性トロンボモジュリン類似体
US20130085111A1 (en) Production of human c1 inhibitor in human cells
US8017750B2 (en) Haemocoagulase
JP4157644B2 (ja) 高純度可溶性トロンボモジュリンの製造方法
CN105732814A (zh) 抗人血管性血友病因子a3区的人鼠嵌合单克隆抗体及其制备方法和应用
JP4804356B2 (ja) 第ＶＩＩＩ因子及びその誘導体の高発現レベルのための改変されたｃＤＮＡ
CN117126832B (zh) 一种重组人凝血因子ix融合蛋白及其制备方法
CN120400110A (zh) 一种经修饰的重组人凝血酶及其制备方法、用途
JPH0453489A (ja) プロウロキナーゼの遺伝子工学的製造法
EP1208212A1 (en) Fibrin sealant as a transfection/transformation vehicle for gene therapy
HK1151184B (en) Recombinant fibrinogen

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100304

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100304

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120605

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120830

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120906

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121204

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130108

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130508

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20130710

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20130816